SS

Sunita Singh

Active Director Director DIN 02403513
DIN 02403513 First appointment Feb 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2005
Shareholding value •••• Premium profile

About Sunita Singh

Data last updated:

Sunita Singh is a Director at Arromed Healthcare Private Limited (since 2005). The company operates in Pharma. Arromed Healthcare Private Limited reported revenue of ₹1.19 Cr (FY 2025).

DIN 02403513
Primary Designation Director
Industry Pharma
First Appointment 17 Feb 2005
Oldest Company Age 21 yrs
Largest company Arromed Healthcare Private Limited · ₹1.19 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arromed Healthcare Private Limited U24230UP2005PTC029518
Director17 Feb 20052005₹1.19 Cr (FY 2025)Active

Board colleagues of Sunita Singh

Directorship timeline

Open interactive timeline →
Arromed Healthcare Private Limited
Premium access

Shareholding and investment profile for Sunita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Singh

Sunita Singh currently holds 1 directorship: Arromed Healthcare Private Limited (Director, since 17 Feb 2005, revenue ₹1.19 Cr (FY 2025)).

Sunita Singh was first appointed on 17 Feb 2005 as Director at Arromed Healthcare Private Limited.

The current boards of Sunita Singh's companies include Bhuvesh Kishor Singh (Arromed Healthcare Private Limited), Yugal Kishore Singh (Arromed Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available